Lanreotide autogel/depot (LAN) in lung neuroendocrine tumours (NETs): The randomized, double-blind, placebo (PBO)-controlled, international phase 3 SPINET study Meeting Abstract


Authors: Reidy-Lagunes, D.; Kulke, M. H.; Wolin, E. M.; Singh, S.; Ferone, D.; Hörsch, D.; Mirakhur, B.; Hoffmanns, P.; Houchard, A.; Caplin, M.; Baudin, E.
Abstract Title: Lanreotide autogel/depot (LAN) in lung neuroendocrine tumours (NETs): The randomized, double-blind, placebo (PBO)-controlled, international phase 3 SPINET study
Meeting Title: 14th Annual European Neuroendocrine Tumor Society (ENETS) Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease
Keywords: lanreotide; lung nets
Journal Title: Neuroendocrinology
Volume: 105
Issue: Suppl. 1
Meeting Dates: 2017 Mar 8-10
Meeting Location: Barcelona, Spain
ISSN: 0028-3835
Publisher: S. Karger AG  
Date Published: 2017-10-01
Start Page: 209
Language: English
ACCESSION: WOS:000413957900210
PROVIDER: wos
PUBMED: 29069642
DOI: 10.1159/000484263
Notes: Meeting Abstract: K20 -- Individual page numbers not listed on original publication -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Diane Lauren Reidy
    294 Reidy